ストックスクリーナーアプリを入手
61.73
3.42%
2.04
アフターアワーズ：
61.00
-0.73
-1.18%
Royalty Pharma Plc (RPRX) 最新ニュース
Royalty Pharma EVP Christopher Hite Sells 100,000 Shares and Donates 16,800 Shares to Charity - kalkinemedia.com
Royalty Pharma (NASDAQ:RPRX) EVP Christopher Hite Sells 100,000 Shares of Stock - MarketBeat
Royalty Pharma (NASDAQ: RPRX) exec sells 100K shares, donates stock - Stock Titan
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighHere's What Happened - MarketBeat
Royalty Pharma stock hits all-time high at 60.44 USD - Investing.com
Royalty Pharma stock hits all-time high at 60.44 USD By Investing.com - Investing.com Nigeria
Commerzbank Aktiengesellschaft FI Invests $1.20 Million in Royalty Pharma PLC $RPRX - MarketBeat
How Investors Are Reacting To Royalty Pharma (RPRX) Buying Rusfertide Royalties From Zealand Pharma - simplywall.st
Royalty Pharma (NASDAQ: RPRX) holder plans multi-million share sale - Stock Titan
Royalty Pharma EVP & CFO Terrance Coyne sells $645k in shares - Investing.com South Africa
Royalty Pharma (RPRX) CFO sells 11,002 shares in trading plan - Stock Titan
LYNWOOD PRICE CAPITAL MANAGEMENT LP's Royalty Pharma PLC(RPRX) Holding History - GuruFocus
Royalty Pharma Plc (RPRX) Stock Analysis: Unpacking A 10.49% Potential Upside - DirectorsTalk Interviews
S&CO Inc. Buys Shares of 358,302 Royalty Pharma PLC $RPRX - MarketBeat
Here’s How Much You Would Have Made Owning Royalty Pharma Stock In The Last 10 Years - Benzinga
Royalty Pharma (RPRX) Following Mixed Earnings Still Looks Close To Fair Value - Sahm
Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story? - Yahoo Finance
Royalty Pharma (RPRX) holder TPC RP EPA1 LLC eyes 11,002-share stock sale - Stock Titan
Royalty Pharma Locks in $100M Zealand Pharma Funding Pact for Blood Disorder Drug - Benzinga
Royalty Pharma (RPRX) Crossed Above the 20-Day Moving Average: What That Means for Investors - Yahoo Finance
Royalty Pharma (NASDAQ:RPRX) Hits Perfect Technical Rating with Breakout Setup - ChartMill
Royalty Pharma (RPRX) files to potentially sell 11.9M Class A shares - Stock Titan
RPRX (RPRX) investor files to sell 125,000 Class A shares on NASDAQ - Stock Titan
Zealand gains $100M in funding from Royalty Pharma (RPRX:NASDAQ) - Seeking Alpha
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million - The Manila Times
Zealand Pharma sells rusfertide royalty rights for $100 million - Investing.com
Zealand Pharma sells rusfertide royalty rights for $100 million By Investing.com - Investing.com UK
Behavioral Patterns of RPRX and Institutional Flows - Stock Traders Daily
Royalty Pharma plc and Zealand Pharma A/S Enter into Rusfertide Funding Agreement for $100 Million - marketscreener.com
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide - The Manila Times
Royalty Pharma PLC (NASDAQ:RPRX) Plans Quarterly Dividend of $0.23 - MarketBeat
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript - AOL.com
Royalty Pharma PLC $RPRX Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Royalty Pharma PLC $RPRX Stake Boosted by Handelsbanken Fonder AB - MarketBeat
How Royalty Pharma’s Stronger H1 2026 Earnings and New Academic Focus At Royalty Pharma (RPRX) Has Changed Its Investment Story - webull.com
Should Income Investors Look At Royalty Pharma plc (NASDAQ:RPRX) Before Its Ex-Dividend? - webull.com
Royalty Pharma publishes transcript of Q2 2026 financial results call - Bitget
A3LZUK Bond Profile — Key Metrics - TradingView
A3LZUK Bond Coupon Profile — Rate & Payments - TradingView
Royal Bank of Canada Purchases 23,479 Shares of Royalty Pharma PLC $RPRX - MarketBeat
RPHC5824520 Bond Risk Profile - TradingView
Royalty Pharma (NASDAQ:RPRX) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Royalty Pharma (RPRX) CEO gets share award and gifts partnership interests - Stock Titan
Royalty Pharma plc (RPRX) CFO logs equity award and 18,500-share gift - Stock Titan
Royalty Pharma (NASDAQ: RPRX) EVP gets 11,002-share Class A equity award - Stock Titan
Royalty Pharma (RPRX) EVP gets 8,252 shares, gifts LP interests - Stock Titan
Royalty Pharma plc (RPRX) Stock Forecasts - Yahoo! Finance Canada
JPMorgan Chase & Co. Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price - MarketBeat
Royalty Pharma PLC (RPRX) Stock News Today - TradingKey
Bank of America Corp DE Buys 786,921 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Announces Earnings Results, Misses Expectations By $1.23 EPS - MarketBeat
Royalty Pharma Q2 2026 slides: guidance raised on strong growth - Investing.com
Royalty Pharma Q2 Earnings Call Highlights - MarketBeat
Royalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance - Yahoo Finance
BofA raises Royalty Pharma stock price target on strong results By Investing.com - Investing.com South Africa
BofA raises Royalty Pharma stock price target on strong results - Investing.com
Earnings call transcript: Royalty Pharma lifts 2026 outlook in strong Q2 - Investing.com
Royalty Pharma plc 2026 Q2ResultsEarnings Call Presentation (NASDAQ:RPRX) 2026-08-05 - Seeking Alpha
Royalty Pharma PLC reports results for the quarter ended June 30Earnings Summary - TradingView
Royalty Pharma (RPRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Royalty Pharma plc 2026: Revenue $674.14M, EPS $0.04— 10-Q Summary - TradingView
Royalty Pharma (Nasdaq: RPRX) lifts H1 2026 cash flow and profit - Stock Titan
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
21.96%
0.62%
大文字化:
|
ボリューム (24 時間):